` Comparison: CLPBY vs ALC - Alpha Spread

CLPBY
vs
ALC

Over the past 12 months, CLPBY has underperformed ALC, delivering a return of -30% compared to the ALC's 24% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CLPBY
ALC
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CLPBY Intrinsic Value
HIDDEN
Show
ALC Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Coloplast A/S
OTC:CLPBY
7.63 USD
Alcon AG
SIX:ALC
64.6 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CLPBY, ALC

CLPBY
ALC
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Coloplast A/S
Revenue
Alcon AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CLPBY, ALC

CLPBY
ALC
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Coloplast A/S
OTC:CLPBY
Alcon AG
SIX:ALC
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CLPBY
67.9%
ALC
54.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

Operating Margin

CLPBY
27.3%
ALC
13.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

Net Margin

CLPBY
14.3%
ALC
10.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

FCF Margin

CLPBY
19.1%
ALC
14.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

ROE

CLPBY
25.1%
ALC
4.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

ROA

CLPBY
8.2%
ALC
3.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

ROIC

CLPBY
10.6%
ALC
4.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

ROCE

CLPBY
19.3%
ALC
4.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Coloplast A/S
Alcon AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CLPBY, ALC

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CLPBY, ALC

Performance Gap Between CLPBY and ALC
HIDDEN
Show

Performance By Year
CLPBY, ALC

Loading
CLPBY
ALC
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CLPBY to other stocks
MDLN
Medline Inc
M
More expensive
vs CLPBY
7741
Hoya Corp
More expensive
vs CLPBY
ALGN
Align Technology Inc
More expensive
vs CLPBY
CTEC
ConvaTec Group PLC
More expensive
vs CLPBY
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett